ENDPOINTS

ICER finds GSK inhalers offer advantages over generics

The higher prices of two COPD inhalers from GSK that are targeted in the second round of government drug price negotiations are justified because of several advantages over generic competitors, according to a new report ...

Mar 3, 2025 - 14:12
 0
ICER finds GSK inhalers offer advantages over generics
The higher prices of two COPD inhalers from GSK that are targeted in the second round of government drug price negotiations are justified because of several advantages over generic competitors, according to a new report ...
Read More

Tags:

Previous Article

Watch SpaceX launch is Starship Flight 8 megarocket test flight today

Next Article

After Phase 3 depression setback, Neumora pauses two trials to make changes, scr...

Related Posts

FDA places two Indian manufacturers on import alerts over bare footprints and blocked inspectors

FDA places two Indian manufacturers on import alerts ov...

Feb 19, 2025  0

Sanofi, AstraZeneca back Teva's call to rehear case on patent listings

Sanofi, AstraZeneca back Teva's call to rehear case on ...

Feb 9, 2025  0

Digital health dealmaking is heating up

Digital health dealmaking is heating up

Feb 9, 2025  0